Literature DB >> 22588043

Recurrent respiratory papillomatosis.

Naren N Venkatesan1, Harold S Pine, Michael P Underbrink.   

Abstract

Recurrent respiratory papillomatosis (RRP) is a rare, benign disease with no known cure. RRP is caused by infection of the upper aerodigestive tract with the human papillomavirus (HPV). Passage through the birth canal is thought to be the initial transmission event, but infection may occur in utero. HPV vaccines have helped to provide protection from cervical cancer; however, their role in the prevention of RRP is undetermined. Clinical presentation of initial symptoms of RRP may be subtle. RRP course varies, and current management focuses on surgical debulking of papillomatous lesions with or without concurrent adjuvant therapy.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22588043      PMCID: PMC3682415          DOI: 10.1016/j.otc.2012.03.006

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  134 in total

1.  Recurrent respiratory papillomatosis arising in trachea not affecting larynx.

Authors:  Qingliang Xue; Jianxin Wang
Journal:  Intern Med       Date:  2010-08-02       Impact factor: 1.271

2.  Carcinogenicity of human papillomaviruses.

Authors:  Vincent Cogliano; Robert Baan; Kurt Straif; Yann Grosse; Béatrice Secretan; Fatiha El Ghissassi
Journal:  Lancet Oncol       Date:  2005-04       Impact factor: 41.316

3.  Recurrent respiratory papillomatosis associated with gastroesophageal reflux disease in children.

Authors:  G Borkowski; P Sommer; T Stark; H Sudhoff; H Luckhaupt
Journal:  Eur Arch Otorhinolaryngol       Date:  1999       Impact factor: 2.503

4.  Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types.

Authors:  M Thomas; L Banks
Journal:  J Gen Virol       Date:  1999-06       Impact factor: 3.891

5.  The characteristics of human papillomavirus DNA in head and neck cancers and papillomas.

Authors:  T Major; K Szarka; I Sziklai; L Gergely; J Czeglédy
Journal:  J Clin Pathol       Date:  2005-01       Impact factor: 3.411

6.  Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression.

Authors:  Cynthia Go; Mary R Schwartz; Donald T Donovan
Journal:  Ann Otol Rhinol Laryngol       Date:  2003-04       Impact factor: 1.547

7.  Recurrent respiratory papillomatosis--the Manchester experience, 1974-1992.

Authors:  C Hartley; J Hamilton; A R Birzgalis; W T Farrington
Journal:  J Laryngol Otol       Date:  1994-03       Impact factor: 1.469

8.  Long-term response of recurrent respiratory papillomatosis to treatment with lymphoblastoid interferon alfa-N1. Papilloma Study Group.

Authors:  B G Leventhal; H K Kashima; P Mounts; L Thurmond; S Chapman; S Buckley; D Wold
Journal:  N Engl J Med       Date:  1991-08-29       Impact factor: 91.245

9.  Clinical effects of photodynamic therapy on recurrent laryngeal papillomas.

Authors:  A L Abramson; M J Shikowitz; V M Mullooly; B M Steinberg; C A Amella; H R Rothstein
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1992-01

10.  Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children.

Authors:  Lee M Akst; Walter Lee; Christopher Discolo; Daniel Knott; Abbas Younes; Peter J Koltai
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-08
View more
  26 in total

1.  Immunologic responses to a novel DNA vaccine targeting human papillomavirus-11 E6E7.

Authors:  Julie Ahn; Shiwen Peng; Chien-Fu Hung; Richard B S Roden; Tzyy-Choou Wu; Simon R Best
Journal:  Laryngoscope       Date:  2017-07-17       Impact factor: 3.325

Review 2.  Hoarseness-causes and treatments.

Authors:  Rudolf Reiter; Thomas Karl Hoffmann; Anja Pickhard; Sibylle Brosch
Journal:  Dtsch Arztebl Int       Date:  2015-05-08       Impact factor: 5.594

3.  Use of cidofovir in HPV patients with recurrent respiratory papillomatosis.

Authors:  M Grasso; M Remacle; V Bachy; S Van Der Vorst; G Lawson
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-23       Impact factor: 2.503

4.  Juvenile recurrent respiratory papillomatosis: A rare masquerade of asthma.

Authors:  W H Boo; P Rajan; S M Ching; P Y Lee
Journal:  Malays Fam Physician       Date:  2015-08-31

5.  Genetic dysregulation in recurrent respiratory papillomatosis.

Authors:  Regina Rodman; Simukayi Mutasa; Crystal Dupuis; Heidi Spratt; Michael Underbrink
Journal:  Laryngoscope       Date:  2014-03-11       Impact factor: 3.325

6.  Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis.

Authors:  Scott B Drutman; Filomeen Haerynck; Franklin L Zhong; David Hum; Nicholas J Hernandez; Serkan Belkaya; Franck Rapaport; Sarah Jill de Jong; David Creytens; Simon J Tavernier; Katrien Bonte; Sofie De Schepper; Jutte van der Werff Ten Bosch; Lazaro Lorenzo-Diaz; Andy Wullaert; Xavier Bossuyt; Gérard Orth; Vincent R Bonagura; Vivien Béziat; Laurent Abel; Emmanuelle Jouanguy; Bruno Reversade; Jean-Laurent Casanova
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-04       Impact factor: 11.205

Review 7.  Human genetic dissection of papillomavirus-driven diseases: new insight into their pathogenesis.

Authors:  Vivien Béziat
Journal:  Hum Genet       Date:  2020-05-20       Impact factor: 4.132

8.  Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis.

Authors:  Irena Hočevar-Boltežar; Mojca Matičič; Maja Sereg-Bahar; Nina Gale; Mario Poljak; Boštjan Kocjan; Miha Zargi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-26       Impact factor: 2.503

Review 9.  Impact of HPV vaccination on anogenital warts and respiratory papillomatosis.

Authors:  Zoon Wangu; Katherine K Hsu
Journal:  Hum Vaccin Immunother       Date:  2016-05-23       Impact factor: 3.452

10.  Xenograft model for therapeutic drug testing in recurrent respiratory papillomatosis.

Authors:  Julie Ahn; Justin A Bishop; Belinda Akpeng; Sara I Pai; Simon R A Best
Journal:  Ann Otol Rhinol Laryngol       Date:  2014-08-13       Impact factor: 1.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.